Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
0.1750
+0.0040 (2.34%)
At close: Apr 2, 2026, 4:00 PM EDT
0.1781
+0.0031 (1.77%)
After-hours: Apr 2, 2026, 7:48 PM EDT
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $7.85 million as of April 2, 2026. Its market cap has decreased by -90.11% in one year.
Market Cap
7.85M
Enterprise Value
8.96M
1-Year Change
-90.11%
Ranking
Category
Stock Price
$0.18
Market Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $7.85M, a decrease of -97.73%. That is a compound annual growth rate of -54.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 7.85M | -52.43% |
| Dec 31, 2025 | 16.51M | -79.39% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
| May 26, 2021 | 346.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bolt Biotherapeutics | 8.24M |
| Aprea Therapeutics | 8.19M |
| Evogene | 8.11M |
| GridAI Technologies | 8.03M |
| TransCode Therapeutics | 7.89M |
| Kiora Pharmaceuticals | 7.66M |
| CollPlant Biotechnologies | 7.63M |
| Creative Medical Technology Holdings | 7.59M |